Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest 
VANCOUVER, British Columbia, April 24, 2018 -- via NetworkWire – Sunniva Inc. ("Sunniva" or the “Company") (CSE:SNN) (OTCQX:SNNVF) announced today that it will delay its fourth quarter and year ended December 31, 2017 earnings release and the subsequent earnings call, previously scheduled for April 24, 2018 and April 25, 2018, respectively. The Company now intends to release its results on April 30, 2018, after markets close. The delay is required for the Company’s auditors to complete their final audit procedures.
The Company's executive management will discuss the results during the rescheduled conference call on Tuesday, May 1, 2018 at 11:30 am Eastern Time/8:30 am Pacific Time. To participate in the call, please dial 1-800-319-4610, or (604) 638-5340. An audio replay will be available shortly after the call by dialing 1-855-669-9658 or (604) 674- 8052 and entering access code 5312. The replay will be available for two weeks after the call.
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current good manufacturing practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.
For more information please visit: www.sunniva.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
Dr. Anthony Holler
Chairman and Chief Executive Officer
Investor Relations Contact:
George Jurcic
Manager, Investor Relations
587-430-0680
